ATE509932T1 - Polymorphe form von 6-(4-chlorphenyl)-2,2- - Google Patents

Polymorphe form von 6-(4-chlorphenyl)-2,2-

Info

Publication number
ATE509932T1
ATE509932T1 AT06723557T AT06723557T ATE509932T1 AT E509932 T1 ATE509932 T1 AT E509932T1 AT 06723557 T AT06723557 T AT 06723557T AT 06723557 T AT06723557 T AT 06723557T AT E509932 T1 ATE509932 T1 AT E509932T1
Authority
AT
Austria
Prior art keywords
ppm
chlorphenyl
polymorphous form
pyrrolizin
adamantane
Prior art date
Application number
AT06723557T
Other languages
English (en)
Inventor
Wolfgang Albrecht
Thomas Kammermeier
Hans-Guenter Striegel
Philipp Merckle
Stefan Laufer
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Application granted granted Critical
Publication of ATE509932T1 publication Critical patent/ATE509932T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT06723557T 2005-03-21 2006-03-20 Polymorphe form von 6-(4-chlorphenyl)-2,2- ATE509932T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005012971A DE102005012971A1 (de) 2005-03-21 2005-03-21 Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
PCT/EP2006/002539 WO2006100019A1 (en) 2005-03-21 2006-03-20 Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid

Publications (1)

Publication Number Publication Date
ATE509932T1 true ATE509932T1 (de) 2011-06-15

Family

ID=36568591

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06723557T ATE509932T1 (de) 2005-03-21 2006-03-20 Polymorphe form von 6-(4-chlorphenyl)-2,2-

Country Status (15)

Country Link
US (1) US8034837B2 (de)
EP (1) EP1861404B1 (de)
JP (1) JP5009280B2 (de)
CN (1) CN101160311B (de)
AT (1) ATE509932T1 (de)
AU (1) AU2006226625B2 (de)
CA (1) CA2602224A1 (de)
DE (1) DE102005012971A1 (de)
ES (1) ES2367274T3 (de)
MX (1) MX2007011455A (de)
PL (1) PL1861404T3 (de)
PT (1) PT1861404E (de)
RU (1) RU2007138924A (de)
SI (1) SI1861404T1 (de)
WO (1) WO2006100019A1 (de)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260451A (en) 1989-05-11 1993-11-09 Merckle Gmbh Substituted pyrrole compounds and use thereof in pharmaceutical compositions
DE3915450A1 (de) * 1989-05-11 1990-11-15 Gerd Prof Dr Dannhardt Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
DE4419246A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419247A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
DE4419315A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
JP2000504723A (ja) * 1996-02-13 2000-04-18 ジー．ディー．サール アンド カンパニー シクロオキシゲナーゼ―２阻害剤および５―リポキシゲナーゼ阻害剤投与の免疫抑制効果
EE05125B1 (et) * 2000-01-28 2009-02-16 Merckle Gmbh 6-(4-klorofenl)-2,2-dimetl-7-fenl-2,3-dihdro-1H-prrolisiin-5-l„„dikhappe valmistamismeetod
DE10141285A1 (de) 2001-08-23 2003-03-27 Merckle Gmbh Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
ES2275218T3 (es) * 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.

Also Published As

Publication number Publication date
US8034837B2 (en) 2011-10-11
US20090209610A1 (en) 2009-08-20
MX2007011455A (es) 2007-12-06
EP1861404A1 (de) 2007-12-05
CA2602224A1 (en) 2006-09-28
PT1861404E (pt) 2011-09-01
WO2006100019A1 (en) 2006-09-28
CN101160311B (zh) 2010-11-24
JP2008535809A (ja) 2008-09-04
RU2007138924A (ru) 2009-04-27
EP1861404B1 (de) 2011-05-18
ES2367274T3 (es) 2011-11-02
SI1861404T1 (sl) 2011-11-30
AU2006226625A1 (en) 2006-09-28
AU2006226625B2 (en) 2011-04-21
CN101160311A (zh) 2008-04-09
JP5009280B2 (ja) 2012-08-22
PL1861404T3 (pl) 2011-12-30
DE102005012971A1 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
ECSP066375A (es) Forma cristalina gamma de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
CR8249A (es) Forma cristalina gamma del clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que lo contienen
NZ596107A (en) Antiviral compounds and methods
EA200870460A1 (ru) Производные циклогексилпиразол-лактама в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы 1
DK2049475T3 (da) Cyclohexyl-substituerede pyrrolidinoner som inhibitorer af 11-beta-hydroxysteroid dehydrogenase1
EA200870462A1 (ru) Производные бифениламидлактама в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы 1
ECSP066376A (es) FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
NO20070445L (no) Pyrimidinderivater.
TN2011000245A1 (en) Organic compounds
CL2011002115A1 (es) Compuestos derivados de 5-fenil-1h-piridin-2-ona y 5-fenil-pirazin-2-ona, inhibidores de la tirosina-quinasa de bruton (btk); proceso de preparación de los compuestos, compuesto intermediario, composición farmacéutica y uso en el tratamiento de enfermedades inflamatorias y/o autoinmunes.
NI200600240A (es) FORMA CRISTALINA Delta-d CLORHIDRATO DE LA IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN, Y LAS COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
DK2035379T3 (da) Inhibitorer af 11-beta-hydroxysteroiddehydrogenase 1
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
DK2049513T3 (da) Piperidinylsubstituerede pyrrolidinoner som inhibitorer af 11-beta-hydroxysteroiddehydrogenase 1
TW200833324A (en) Sulfonamide derivatives
EA201070423A1 (ru) Диарильные соединения оксадиазолов
WO2006114401A3 (en) Novel cyclic amines
PL1620425T3 (pl) Podstawione 3-cyjanotiofenoacetamidy jako antagoniści receptora glukagonu
NO20085317L (no) Imidazoazepinonforbindelser
EA200701810A1 (ru) Производное изоксазолина и новый способ его получения
TW200716568A (en) 1H-quinazoline-2,4-diones
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
DE602006009789D1 (de) Acetylenderivate
CL2012001010A1 (es) Compuesto 4-[etil(dimetil)amonio]butanoato; procesos de preparacion de este compuesto; y su uso en el tratamiento de enfermedades cardiovasculares.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties